Inito
Latest round
- Series B
Last raised
- Dec 2025
Total raised
- $35M
Investors
- 2
About Inito
Inito, Inc.Founded in 2015, Inito, Inc. is dedicated to developing fertility monitoring solutions. The company's flagship product, the Inito Fertility Monitor, was launched recently to support individuals in tracking their fertility hormones. Aayush Rai, the CEO and co-founder, has played a crucial role in the company's strategic vision. Inito Health Inc. specializes in the development and sale of the Inito Fertility Monitor, an innovative device designed to track and analyze fertility hormones in users' urine. This monitor uniquely measures four key hormones—Estrogen, Luteinizing Hormone (LH), Progesterone, and Follicle Stimulating Hormone (FSH)—on a single test strip, providing personalized insights into ovulation patterns and fertility windows. The device is particularly beneficial for women with irregular menstrual cycles or conditions such as Polycystic Ovary Syndrome (PCOS), as it offers detailed hormone data that can help users identify their most fertile days and confirm successful ovulation. The Inito Fertility Monitor is aimed primarily at individuals and couples seeking to conceive, and its market extends across North America and select regions in Europe, offering a sophisticated, accessible solution for fertility tracking at home.Inito generates revenue primarily through direct sales of its flagship product, the Inito Fertility Monitor, along with associated test strip refills. In the most recent year, the revenue amount was USD 588,967 with an EBITDA of USD -315,162. Customers purchase the initial monitor, which includes a starter kit, and subsequently acquire additional test strips via the Inito mobile application. The pricing structure is designed for direct-to-consumer transactions, allowing users to conveniently manage their reproductive health from home. By incentivizing repeat purchases through the need for continuous hormone monitoring, Inito fosters ongoing customer relationships while contributing to its revenue stream.In November 2023, Inito, Inc. The company aims to expand its product line with new innovations in fertility monitoring and enhance its mobile application for a better user experience. Additionally, Inito plans to expand its market reach in Europe and North America over the next year, targeting specific regions to increase accessibility to its products.
Who invested in Inito
2 investors across 2 rounds
See all investors in Inito
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Inito
Who invested in Inito?
Inito has 2 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Inito raised?
Inito has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Inito last raise money?
Inito's most recent round on record is a Series B, in Dec 2025.
What does Inito do?
Inito is a medical devices & equipment company.
Where is Inito headquartered?
Inito is headquartered in Houston, US.
Which VCs invest in companies like Inito?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at Inito's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series B
Raising like Inito? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.